Target intelligence / Profile preview

L-type Calcium Channel Alpha-1 Subunit (Cav1.2) (Cav1.2)

Target
Cav1.2
Molecular classification
Voltage-gated calcium channel, Ion channel, CaV1.x subfamily
01

Overview

The L-type calcium channel alpha-1 subunit, specifically Cav1.2, is the principal pore-forming and voltage-sensing component of L-type voltage-gated calcium channels. These channels mediate Ca²⁺ influx into excitable cells in response to membrane depolarization, triggering muscle contraction, hormone secretion, and neuronal signaling. It is a large protein (~170–240 kDa) composed of four homologous domains (I–IV), each containing six transmembrane segments (S1–S6). The S4 segment acts as the voltage sensor, and the region between S5 and S6 forms the ion-selective pore. The channel complex includes auxiliary subunits (α₂δ, β, +/- γ) that modulate trafficking, gating kinetics, pharmacology, and surface expression. Cav1.2 channels mediate high-voltage activated (HVA) currents and are crucial for cardiac myocyte excitation-contraction coupling, smooth muscle contraction, neuronal dendritic signaling, and neuroendocrine regulation. L-type channels containing Cav1.2 are sensitive to dihydropyridine drugs (“DHP receptors”), phenylalkylamines, benzothiazepines and mutations or dysregulation can lead to various pathologies.

Other names
α₁C subunitCACNA1CDihydropyridine receptor (DHP receptor)
02

Mechanism of action

L-type calcium channel blockade

03

Biological functions

Calcium ion transmembrane transportCardiac myocyte excitation-contraction couplingSmooth muscle contractionNeuronal dendritic signalingNeuroendocrine regulation
04

Disease associations

Cardiac arrhythmiasHypertensionNeuropsychiatric disorders
05

Safety considerations

Cardiac side effectsHypotension
06

Interacting drugs

Dihydropyridines

2 more in the full profile.

Beyond the preview

Go deeper on L-type Calcium Channel Alpha-1 Subunit (Cav1.2) (Cav1.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-type Calcium Channel Alpha-1 Subunit (Cav1.2) (Cav1.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call